November 26, 2013 / 1:05 PM / 4 years ago

BRIEF-BioLine Rx U.S.-listed shares up 7.3 percent premarket

NEW YORK, Nov 26 (Reuters) - BioLine RX Ltd : * U.S.-listed shares up 7.3 percent premarket after phase 2a trial results for

inflammatory bowel disease treatment

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below